15Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: Modulation of constitutive activity by the recombinant wild-type human 5-HT6 receptor was investigated with a series of 5-HT6 receptor ligands by monitoring the cAMP signalling pathway. The impact of the mutation S267K near the B261BXXB265CIII-loop motif was analyzed on the magnitude of constitutive receptor activity as previously conflicting results have been reported. Methods: The wild-type 5-HT6 receptor plasmid was obtained by PCR and the mutant S267K5-HT6 receptor was constructed by site-directed mutagenesis and stably transfected in HEK-293F cells by electroporation. The cAMP signalling pathway was monitored as a functional read-out to investigate ligands' responses using homogeneous time resolved fluorescence. Results: Constitutive activity was present both at wild-type and mutant S267K 5-HT6 receptors. Negative efficacy (Emax, % versus basal) as observed at nanomolar concentrations with SB-271046 was larger for mutant (- 92 ± 1%) than wild-type 5-HT6 receptor (- 45 ± 1%). Ro 04-6790 also demonstrated negative efficacy at the wild-type 5-HT6 receptor with a magnitude similar to SB-271046 but with a 36-fold lower potency. MS-245 demonstrated at nanomolar concentrations intermediate negative efficacy; - 48 ± 3% and - 16 ± 2% at mutant and wild-type 5-HT6 receptor, respectively. The 5-HT-mediated cAMP response was blocked by SB-271046, MS-245 and Ro 04-6790 to their respective level of negative efficacy with pKB values fitting with their binding pKivalues. E-6801 was a highly potent (pEC50: 10.17 to 10.19) and efficacious agonist (+ 98 to + 102% versus 5-HT) at both wild-type and mutant 5-HT6 receptors. Discussion: The recombinant wild-type human 5-HT6 receptor is constitutively active in HEK-293F cells and displays a high resolution to monitor efficacy properties of 5-HT6 receptor ligands. The resolution capacity to differentiate between efficacy properties of 5-HT6 receptor ligands, in particular for negative efficacy, can be further enhanced by monitoring the mutant S267K 5-HT6 receptor. © 2006 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Romero, G., Pujol, M., Pérez, P., Buschmann, H., & Pauwels, P. J. (2007). Whole spectrum analysis of ligand efficacy at constitutively active human wild-type and S267K 5-HT6 receptors in HEK-293F cells. Journal of Pharmacological and Toxicological Methods, 55(2), 144–150. https://doi.org/10.1016/j.vascn.2006.04.007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free